 |
| Proton Therapy Market |
Proton therapy offers more benefits over traditional photon-based therapies as protons can target tumors with greater precision. Proton therapy involves the use of proton beams to treat cancerous tumors. It delivers a higher radiation dose to tumors while minimizing exposure of surrounding healthy tissues and reduces side effects.
The
global proton therapy market is estimated to be valued at US$ 2763.2 Mn in 2023 and is expected to exhibit a CAGR of 5.1% over the forecast period
2023 to 2030, as highlighted in a new report published by Coherent Market
Insights.
Market key trends:
Advancements in proton therapy technologies have been a key growth driver in
the proton therapy market. Major proton therapy vendors have invested
significantly in research and development to develop newer technologies and
devices that can improve accuracy and efficiency of treatment delivery. For
instance, companies are focusing on developing techniques like pencil beam
scanning that involves dynamic placement and movement of proton beams to
precisely conform to the shape of tumors. Pencil beam scanning improves dose
distributions and minimizes radiation exposure to adjacent critical structures.
Growing adoption of such advanced technologies is supporting market growth.
Additionally, vendors are also developing multi-room treatment centers to
enhance patient accessibility and capacity of existing proton therapy centers.
Such ongoing technological advancements are poised to accelerate the growth of
the proton therapy market over the forecast period.
Segment Analysis
The global proton therapy market is dominated by the hospital sub-segment owing
to the fact that proton therapy is highly complex and expensive treatment
available mostly in hospitals. Hospitals have well-equipped centers for cancer
treatment and can afford the high cost of installation and maintenance of
proton therapy systems. In addition, the availability of other advanced
facilities for cancer diagnosis and treatment make hospitals a preferred choice
for proton therapy.
Key Takeaways
The global Proton
Therapy Market Share is expected to witness high growth over the
forecast period of 2023 to 2030. The rising incidence of cancer worldwide and
advantages of proton therapy over photon therapy are driving the demand. The
global proton therapy market is estimated to be valued at US$ 2763.2 Mn in 2023
and is expected to exhibit a CAGR of 5.1% over the forecast period 2023 to
2030.
Regional analysis
North America currently dominates the global proton therapy market owing to
robust healthcare infrastructure and high adoption of advanced cancer treatment
technologies. The USA has the highest number of proton therapy centers
globally. However, the Asia Pacific region is anticipated to grow at the
fastest pace during the forecast period due to rising healthcare spending of
countries like China and India and increasing focus on cancer treatment
infrastructure development.
Key players
Key players operating in the proton therapy market include Varian Medical
Systems, Hitachi, Ion Beam Applications (IBA), Mevion Medical Systems, Sumitomo
Heavy Industries, ProTom International, Mitsubishi Electric Corporation,
ProNova Solutions, LLC. Varian Medical Systems dominated the market in 2023 due
to its large portfolio of proton therapy systems and service solutions.
For more insights, read- https://www.ukwebwire.com/proton-therapy-market-trends-size-and-share-analysis/
Comments
Post a Comment